News
Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...
"Uveal Melanoma Market Insight, Epidemiology and Market Forecast - 2034"The uveal melanoma treatment market is experiencing ...
DelveInsight's,“ Thyroid Cancer Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 51+ ...
The clinical benefits of exercise-based cardiac rehabilitation have been less clear for patients with Afib. A meta-analysis ...
With three decades of experience, Labinger will help advance the company’s scientific platform toward key clinical milestones ...
Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...
Explore more
Foundation’s signature charity cycling and walking event – celebrated its 24th year with $1.69 million raised to date to help support cancer survivorship and patient navigation programs.
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
As Keytruda generic competition looms larger on the horizon, the company is hoping to reinvest the savings into pipeline ...
Eleven New Jersey hospitals, including Hackensack University Medical Center, are celebrated for excellence in healthcare, ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best and Safe Dividend Stocks to Buy Now. Bristol-Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results